Nektar Therapeutics (NKTR) Prepaid Assets (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Prepaid Assets came in at $20.4 million in Q1 2026, up 81.16% year-on-year from $11.3 million in Q1 2025, and little changed quarter-over-quarter from $20.5 million in Q4 2025.
Nektar Therapeutics (NKTR) Prepaid Assets (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $20.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 81.16% year-over-year to $20.4 million in Q1 2026; TTM through Mar 2026 was $20.4 million, a 81.16% increase from a year earlier, with the FY2025 full-year figure at $20.5 million, up 238.18% from the prior year.
- Prepaid Assets held at $20.4 million in Q1 2026 per NKTR's latest filing, from $20.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $22.5 million in Q3 2022 and bottomed at $6.1 million in Q4 2024.
- The 5-year median for Prepaid Assets is $11.0 million (2023), against an average of $13.3 million.
- Across the five-year window, Prepaid Assets sank 59.87% in 2023 and jumped 238.18% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $15.8 million in 2022, then sank by 38.14% to $9.8 million in 2023, then slumped by 37.97% to $6.1 million in 2024, then soared by 238.18% to $20.5 million in 2025, then slipped by 0.38% to $20.4 million in 2026.
- Per Business Quant, the three latest NKTR Prepaid Assets figures stand at $20.4 million (Q1 2026), $20.5 million (Q4 2025), and $11.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.44 Mn |
| Dec 31, 2025 | 20.51 Mn |
| Sep 30, 2025 | 11.15 Mn |
| Jun 30, 2025 | 10.66 Mn |
| Mar 31, 2025 | 11.28 Mn |
| Dec 31, 2024 | 6.07 Mn |
| Sep 30, 2024 | 8.93 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 10.74 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 9.60 Mn |
| Mar 31, 2023 | 11.01 Mn |
| Dec 31, 2022 | 15.81 Mn |
| Sep 30, 2022 | 22.51 Mn |
| Jun 30, 2022 | 19.25 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 23.33 Mn |
| Sep 30, 2021 | 20.73 Mn |
| Jun 30, 2021 | 12.60 Mn |